288 related articles for article (PubMed ID: 38179655)
1. The tumor microenvironment: shaping cancer progression and treatment response.
Desai SA; Patel VP; Bhosle KP; Nagare SD; Thombare KC
J Chemother; 2024 Jan; ():1-30. PubMed ID: 38179655
[TBL] [Abstract][Full Text] [Related]
2. Unraveling the tumor microenvironment: Insights into cancer metastasis and therapeutic strategies.
El-Tanani M; Rabbani SA; Babiker R; Rangraze I; Kapre S; Palakurthi SS; Alnuqaydan AM; Aljabali AA; Rizzo M; El-Tanani Y; Tambuwala MM
Cancer Lett; 2024 Jun; 591():216894. PubMed ID: 38626856
[TBL] [Abstract][Full Text] [Related]
3. Current advances in nanoformulations of therapeutic agents targeting tumor microenvironment to overcome drug resistance.
Fakhri S; Moradi SZ; Faraji F; Farhadi T; Hesami O; Iranpanah A; Webber K; Bishayee A
Cancer Metastasis Rev; 2023 Sep; 42(3):959-1020. PubMed ID: 37505336
[TBL] [Abstract][Full Text] [Related]
4. Tumor microenvironment signaling and therapeutics in cancer progression.
Goenka A; Khan F; Verma B; Sinha P; Dmello CC; Jogalekar MP; Gangadaran P; Ahn BC
Cancer Commun (Lond); 2023 May; 43(5):525-561. PubMed ID: 37005490
[TBL] [Abstract][Full Text] [Related]
5. The tumor microenvironment as driver of stemness and therapeutic resistance in breast cancer: New challenges and therapeutic opportunities.
Mehraj U; Ganai RA; Macha MA; Hamid A; Zargar MA; Bhat AA; Nasser MW; Haris M; Batra SK; Alshehri B; Al-Baradie RS; Mir MA; Wani NA
Cell Oncol (Dordr); 2021 Dec; 44(6):1209-1229. PubMed ID: 34528143
[TBL] [Abstract][Full Text] [Related]
6. Taking a Full Snapshot of Cancer Biology: Deciphering the Tumor Microenvironment for Effective Cancer Therapy in the Oncology Clinic.
Dzobo K
OMICS; 2020 Apr; 24(4):175-179. PubMed ID: 32176591
[TBL] [Abstract][Full Text] [Related]
7. Tumor microenvironment: barrier or opportunity towards effective cancer therapy.
Tiwari A; Trivedi R; Lin SY
J Biomed Sci; 2022 Oct; 29(1):83. PubMed ID: 36253762
[TBL] [Abstract][Full Text] [Related]
8. Disruption of Cell-Cell Communication in Anaplastic Thyroid Cancer as an Immunotherapeutic Opportunity.
Chakraborty S; Carnazza M; Jarboe T; DeSouza N; Li XM; Moscatello A; Geliebter J; Tiwari RK
Adv Exp Med Biol; 2021; 1350():33-66. PubMed ID: 34888843
[TBL] [Abstract][Full Text] [Related]
9. Tumor Microenvironment and Nitric Oxide: Concepts and Mechanisms.
Vedenko A; Panara K; Goldstein G; Ramasamy R; Arora H
Adv Exp Med Biol; 2020; 1277():143-158. PubMed ID: 33119871
[TBL] [Abstract][Full Text] [Related]
10. Nanoparticle-Mediated Targeted Drug Delivery to Remodel Tumor Microenvironment for Cancer Therapy.
Tang L; Mei Y; Shen Y; He S; Xiao Q; Yin Y; Xu Y; Shao J; Wang W; Cai Z
Int J Nanomedicine; 2021; 16():5811-5829. PubMed ID: 34471353
[TBL] [Abstract][Full Text] [Related]
11. Strategy of targeting the tumor microenvironment via inhibition of fibroblast/fibrosis remodeling new era to cancer chemo-immunotherapy resistance.
Tajaldini M; Poorkhani A; Amiriani T; Amiriani A; Javid H; Aref P; Ahmadi F; Sadani S; Khori V
Eur J Pharmacol; 2023 Oct; 957():175991. PubMed ID: 37619785
[TBL] [Abstract][Full Text] [Related]
12. Targeting the tumor microenvironment: Potential strategy for cancer therapeutics.
Babar Q; Saeed A; Tabish TA; Sarwar M; Thorat ND
Biochim Biophys Acta Mol Basis Dis; 2023 Aug; 1869(6):166746. PubMed ID: 37160171
[TBL] [Abstract][Full Text] [Related]
13. Strategies targeting tumor immune and stromal microenvironment and their clinical relevance.
Hu M; Huang L
Adv Drug Deliv Rev; 2022 Apr; 183():114137. PubMed ID: 35143893
[TBL] [Abstract][Full Text] [Related]
14. The Complexity of the Tumor Microenvironment in Hepatocellular Carcinoma and Emerging Therapeutic Developments.
Argentiero A; Delvecchio A; Fasano R; Andriano A; Caradonna IC; Memeo R; Desantis V
J Clin Med; 2023 Dec; 12(23):. PubMed ID: 38068521
[TBL] [Abstract][Full Text] [Related]
15. Addressing CPI resistance in NSCLC: targeting TAM receptors to modulate the tumor microenvironment and future prospects.
Peters S; Paz-Ares L; Herbst RS; Reck M
J Immunother Cancer; 2022 Jul; 10(7):. PubMed ID: 35858709
[TBL] [Abstract][Full Text] [Related]
16. The Tumor Microenvironment in Tumorigenesis and Therapy Resistance Revisited.
Dzobo K; Senthebane DA; Dandara C
Cancers (Basel); 2023 Jan; 15(2):. PubMed ID: 36672326
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic implications of signaling pathways and tumor microenvironment interactions in esophageal cancer.
Khan IR; Sadida HQ; Hashem S; Singh M; Macha MA; Al-Shabeeb Akil AS; Khurshid I; Bhat AA
Biomed Pharmacother; 2024 Jul; 176():116873. PubMed ID: 38843587
[TBL] [Abstract][Full Text] [Related]
18. Dual Relationship Between Stromal Cells and Immune Cells in the Tumor Microenvironment.
Mun JY; Leem SH; Lee JH; Kim HS
Front Immunol; 2022; 13():864739. PubMed ID: 35464435
[TBL] [Abstract][Full Text] [Related]
19. Role of the tumor microenvironment in cancer hallmarks and targeted therapy (Review).
Naser R; Fakhoury I; El-Fouani A; Abi-Habib R; El-Sibai M
Int J Oncol; 2023 Feb; 62(2):. PubMed ID: 36579669
[TBL] [Abstract][Full Text] [Related]
20. The role of tumor-associated macrophage in breast cancer biology.
Choi J; Gyamfi J; Jang H; Koo JS
Histol Histopathol; 2018 Feb; 33(2):133-145. PubMed ID: 28681373
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
